title: Induction immunosuppression with OKT3 monoclonal antibody in cardiac transplant recipients.
authors.affiliation: So Cardiologia, C. Puerta de Hierro, Madrid, Spain.
authors.forename: L A
authors.initials: LA
authors.lastname: Pulpón
authors.forename: P
authors.initials: P
authors.lastname: Domínguez
authors.forename: M
authors.initials: M
authors.lastname: Cháfer
authors.forename: J
authors.initials: J
authors.lastname: Segovia
authors.forename: M G
authors.initials: MG
authors.lastname: Crespo
authors.forename: G
authors.initials: G
authors.lastname: Pradas
authors.forename: R
authors.initials: R
authors.lastname: Burgos
authors.forename: D
authors.initials: D
authors.lastname: Figuera
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D008297:Male; D016853:Muromonab-CD3; D013921:Thrombocytopenia / Q000209:etiology
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D016853:Muromonab-CD3